FEATURED/ARCHIVES (18/05/24)
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Lithium Carbonate as a Treatment for Paliperidone Extended-Release-Induced Leukopenia and Neutropenia in a Patient with Schizoaffective Disorder: A Case Report · May 2016
Articles
BMC Psychiatry
Gender Differences in the Clinical Effects of Fluvoxamine and Milnacipran in Japanese Major Depressive Patients · June 2007
Articles
Psychiatry and Clinical Neurosciences
Discontinuation and Remission Rates and Social Functioning in Patients with Schizophrenia Receiving Second-Generation Antipsychotics: 52-Week Evaluation of JUMPs, a Randomized, Open-Label Study · October 2021
Articles
Psychiatry and Clinical Neurosciences
Efficacy Comparison of Duloxetine and SSRIs at Doses Approved in Japan · January 2015
Articles
Neuropsychiatric Disease and Treatment
A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer’s Disease · September 2015
Articles
Dementia and Geriatric Cognitive Disorders Extra
Psychosocial Intervention for Discontinuing Benzodiazepine Hypnotics in Patients with Chronic Insomnia: A Systematic Review and Meta-Analysis · October 2019
Articles
Sleep Medicine Reviews
Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study · December 2019
Articles
CNS Drugs
Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study · April 2022
Articles
NCBI>Innovations in Clinical Neuroscience
Prevalence of and Risk Factors for Adverse Events in Alzheimer’s Patients Receiving Anti-Dementia Drugs in At-Home Care · April 2020
Articles
PLOS ONE
Combining Schizophrenia and Depression Polygenic Risk Scores Improves the Genetic Prediction of Lithium Response in Bipolar Disorder Patients · November 2021
Articles
Translational Psychiatry
Efficacy of Escitalopram in the Treatment of Social Anxiety Disorder: A Meta-Analysis versus Placebo · February 2016
Articles
European Neuropsychopharmacology
Overview of the Potential Use of Fluvoxamine for COVID-19 and Long COVID · March 2023
Articles
Discover Mental Health
Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment: All-Case Surveillance in Japan · October 2020
Articles
Tohoku Journal of Experimental Medicine
Brexpiprazole as an Adjunctive Treatment in Young Adults with Major Depressive Disorder Who Are in a School or Work Environment · June 2016
Articles
Journal of Affective Disorders
One Patient with Schizophrenia Showed Reduced Drug-Induced Extrapyramidal Symptoms as a Result of an Alternative Regimen of Treatment with Paliperidone 3 and 6 Mg Every Other Day · December 2017
Articles
SAGE Open Medical Case Reports
Long-Lasting Extrapyramidal Symptoms After Multiple Injections of Paliperidone Palmitate to Treat Schizophrenia · October 2018
Articles
Neuropsychiatric Disease and Treatment
Treatment of Delirium with Risperidone in Cancer Patients · July 2012
Articles
Psychiatry and Clinical Neurosciences
Clonazepam Improves Dopamine Supersensitivity in a Schizophrenia Patient: A Case Report · December 2016
Articles
Therapeutic Advances in Psychopharmacology
The Effect of Switching from Oral Low-Dose Aripiprazole to Aripiprazole Once-Monthly 300 Mg on the Quality of Life in Three Patients with Schizophrenia · May 2017
Articles
SAGE Open Medical Case Reports